Last week I wrote about some seemingly encouraging news from uniQure, a firm pursuing a treatment for Huntington’s disease. The FDA had cleared the firm’s BLA. However, I should have given additional background as there’s a more complex backstory here. More on uniQure and HD There’s even been some controversy in this area. For instance, […]

The post Weekly reads: more on uniQure, how not to think about aging, mini lenses appeared first on The Niche.

Read Original